Kudos Pharmaceuticals

Developer of oncology therapies based on the inhibition of DNA repair

placeCambridge, England, United Kingdom calendar_todayFounded 1997 groups8,185 employees language kudospharma.co.uk

Registered entities

Investor mix

10 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital440%
Private equity330%
Other / undisclosed330%
Coming soon